Carvedilol (Compound)

Synonyms:carvedilol, 72956-09-3, Coreg, Dilatrend, Eucardic, Carvedilolum, Kredex, Carvedilolum [Latin], Dimitone, Artist

Pubchem:PUBCHEM:2585

Id:66c05fc2-80ae-550e-8486-60b4216ec995

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Carvedilol's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Carvedilol.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Carvedilol.

Results found

Linked to

	Label	Description
	BRD-A10977446-001-05-5 Substance (Entity type)	A Substance
	Carvedilol negatively regulates DDX42 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol negatively regulates PROM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol positively regulates UCHL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol negatively regulates ZNF331 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol bioactivity Potassium channel subfamily K member 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Carvedilol negatively regulates HLA-DQA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol bioactivity 5-hydroxytryptamine receptor 2B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Carvedilol bioactivity 5-hydroxytryptamine receptor 2C Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Carvedilol negatively regulates STUB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-A10977446-001-05-5

Substance (Entity type)

A Substance

Carvedilol negatively regulates DDX42

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Carvedilol negatively regulates PROM1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Carvedilol positively regulates UCHL1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Carvedilol negatively regulates ZNF331

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Carvedilol bioactivity Potassium channel subfamily K member 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Carvedilol negatively regulates HLA-DQA1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Carvedilol bioactivity 5-hydroxytryptamine receptor 2B

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Carvedilol bioactivity 5-hydroxytryptamine receptor 2C

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Carvedilol negatively regulates STUB1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.